نتایج جستجو برای: taxus

تعداد نتایج: 1272  

Journal: :iranian journal of biotechnology 2013
abolghasem abbasi kajani mohamma reza mofid khalil alami saeid

background: taxol is one of the most important anti-cancer drugs, which is obtained from yew trees (taxus sp.). t+he fist step in side chainassembly of taxol is catalyzed by phenylalanine aminomutase, which converts α-phenylalanine to β-phenylalanine.objectives: in this study, for the fist time, we report on the cloning, preliminary expression and characterization of a full-length gene andcdna ...

Journal: :Circulation. Cardiovascular interventions 2010
John A Ormiston Alexandre Abizaid John Spertus Jean Fajadet Laura Mauri Joachim Schofer Stefan Verheye Joseph Dens Leif Thuesen Christophe Dubois Rainer Hoffmann William Wijns Peter J Fitzgerald Jeffrey J Popma Nathalie Macours Ana Cebrian Hans-Peter Stoll Campbell Rogers Christian Spaulding

BACKGROUND Drug-eluting stents reduce restenosis and reintervention rates but are complicated by stent thrombosis, which may be related to polymer coating. The NEVO sirolimus-eluting coronary stent (NEVO SES) is designed to improve long-term percutaneous coronary intervention safety by combining sirolimus release from reservoirs with bioabsorbable polymer to reduce spatial and temporal polymer ...

Journal: :Cardiovascular research 2007
Gregory J Wilson Jason E Polovick Barbara A Huibregtse Bradley C Poff

OBJECTIVE At 4-year follow-up, paclitaxel-eluting stents (PES, TAXUS) have demonstrated clinical effectiveness in reducing restenosis without increasing death or myocardial infarction. Concerns remain with all drug-eluting stents, however, regarding potential interference with long-term healing, particularly in zones with adjacent stent overlap due to theoretical doubling in both drug release a...

Journal: :Circulation 2003
Antonio Colombo Janusz Drzewiecki Adrian Banning Eberhard Grube Karl Hauptmann Sigmund Silber Dariusz Dudek Stephen Fort Francois Schiele Krysztof Zmudka Giulio Guagliumi Mary E Russell

BACKGROUND Early clinical studies demonstrated the feasibility of local paclitaxel delivery in reducing restenosis after treatment of de novo coronary lesions in small patient populations. METHODS AND RESULTS We conducted a randomized, double-blind trial of 536 patients at 38 medical centers evaluating slow-release (SR) and moderate-release (MR) formulations of a polymer-based paclitaxel-elut...

2010
Marcel A.M. Beijk Margo Klomp Niels J.W. Verouden Nan van Geloven Karel T. Koch José P.S. Henriques Jan Baan Marije M. Vis Esther Scheunhage Jan J. Piek Jan G.P. Tijssen Robbert J. de Winter

AIMS The purpose of this study was to evaluate the Genous(TM) endothelial progenitor cell capturing stent vs. the Taxus Liberté paclitaxel-eluting stent in patients with de novo coronary lesions with a high-risk of coronary restenosis. METHODS AND RESULTS We randomly assigned 193 patients with lesions carrying a high risk of restenosis to have the Genous stent or the Taxus stent implanted. Le...

Journal: :Circulation 2005
Keith D Dawkins Eberhard Grube Giulio Guagliumi Adrian P Banning Krzysztof Zmudka Antonio Colombo Leif Thuesen Karl Hauptman Jean Marco William Wijns Jeffrey J Popma Joerg Koglin Mary E Russell

BACKGROUND Intracoronary polymer-based stent delivery of paclitaxel has been shown to be effective in reducing restenosis in simple coronary lesions, but the evidence base for contemporary use in longer, more complex coronary stenoses is lacking. METHODS AND RESULTS TAXUS VI is a prospective, multicenter, double-blind, randomized trial assessing clinical and angiographic outcomes of the TAXUS...

Journal: :Journal of the American College of Cardiology 2007
Flavio Ribichini Michael Joner Valeria Ferrero Aloke V Finn Johanna Crimins Gaku Nakazawa Eduardo Acampado Frank D Kolodgie Corrado Vassanelli Renu Virmani

OBJECTIVES The aim of this study was to compare the effects of systemic prednisone in combination with a bare-metal stent (BMS) or a paclitaxel-eluting stent (Taxus, Boston Scientific Corp., Natick, Massachusetts) on neointimal inhibition and vessel healing in an atherosclerotic rabbit model. BACKGROUND Inflammation plays a critical role in neointimal formation after coronary artery stenting....

Journal: :Journal of the American College of Cardiology 2006
Stephen G Ellis Jeffrey J Popma Gregg W Stone Mary E Russell

ith great interest I read the report by Weissman et al. (1) regarding ntravascular ultrasound (IVUS) analysis of polymer-based aclitaxel-eluting stents. The investigators stated in the text that positive remodeling assessed as the absolute increase in the xternal elastic membrane volume over time tended to be slightly ore prominent with the TAXUS stent (7.66 48.64 mm vs. 12.29 36.05 mm, respect...

2005
SIGMUND SILBER

Today, drug-eluting stents (DES) are the standard stenting procedure in the USA and in Switzerland. The objective of this analysis is to answer the two questions: what clinically relevant data regarding DES have been published, and is there a clinically relevant difference between the Cypher and the Taxus stents? Twenty-two randomized, controlled studies with a total of 11,118 patients were ide...

Journal: :EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2011
Ryan Saadi Sidney Cohen David Banko Melissa Thompson Michael Duong Nicole Ferko

AIM To use an indirect comparisons approach and conduct a cost analysis comparing four drug-eluting stents (DES) from a United States (US) payer (i.e., fixed-fee reimbursement) perspective. METHODS AND RESULTS Studies were chosen that randomised two or more DES in diabetic patients. A one-year target lesion revascularisation (TLR) risk for Taxus was first derived. Risk Ratios (RRs) for each D...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید